Legal Precision for Life Sciences & Tech

Science Meets Law

Specialized in Biotech, Pharma, MedTech, and ICT. Swiss Law, German Law, and EU Law. GAWEL provides legal advisory, dispute resolution services, and fractional legal leadership.

Book Video Call

The Intersection of Innovation & Regulation

In highly regulated industries like Biotech and MedTech, legal counsel isn’t just about risk avoidance—it’s about strategic enablement. You need a legal partner who efficiently navigates both scientific complexity and the innovation ecosystem, creating opportunities for growth and competitive advantage.

GAWEL provides proactive, pragmatic legal solutions that keep your business moving forward. From R&D agreements to market access and deal-making, the firm provides support to the internal team and facilitates management decisions.

Core Industries

Specialized Focus

01

Biotech & Pharma

R&D • Clinical Trials • Licensing • Contractual Due Diligence for M&A and Corporate Transactions

Comprehensive support for the life cycle of a drug, from discovery to commercialization. Handling MTAs, CTAs, complex licensing agreements, and Contractual Due Diligence for M&A and Corporate Transactions.

02

MedTech

Regulatory • Market Access • Liability • Data Privacy

Navigating the MDR/IVDR landscape with assistance in conformity assessments, market access, liability, and data privacy.

03

ICT & Digital Health

Cybersecurity • SaaS • AI • Cross-border data transfers

Legal frameworks for digital health solutions, AI, cross-border data transfers, and cybersecurity compliance (GDPR/nFADP) in a connected world.

Dr. Claus Gawel

Managing Director

Dr. iur. Claus Gawel, LLM (Uppsala), MCIArb

Rechtsanwalt | Arbitrator | Fractional General/Senior Counsel

Get in Touch

Based in Basel, serving clients globally. Contact the firm to discuss how it can support your business success.

Use the form to request a video call to discuss your business needs and develop a plan to achieve them together.

Modern architecture representing legal precision and innovation